City Of Hope National Med Center

Duarte, California 91010

0 studies enrolling now · 3 studies all time

What they study most

Myelodysplastic Syndromes, Paroxysmal Nocturnal Hemoglobinuria

Studies at this site

• Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria — Running, not enrolling
• A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS). — Stopped early
• Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan. — Completed